Brucella: diagnosis, epidemiology, treatment
Brucella: diagnosis, epidemiology, treatment is a research topic within Small Animals. Science Explorer counts 8.7k research works in it since 1950. 15.9% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the epidemiology, diagnosis, pathogenesis, and control of brucellosis, a re-emerging zoonotic disease. It covers topics such as the global burden of human brucellosis, molecular host-pathogen interactions, vaccine development, and the impact of brucellosis on public health.
- Brucellosis
- Zoonosis
- Epidemiology
- Diagnosis
- Vaccines
- Pathogenesis
- Intracellular Replication
- Host Immune Response
- Genomic Analysis
- Public Health
- Research works
- 8.7k fractional, since 1950
- In the world top 10%
- 1.4k per year above
- Top-10% rate
- 15.9% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +12% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Brucella: diagnosis, epidemiology, treatment research?
By volume, China and India publish the most (237 and 109 works in 2022–2025).
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Brucella: diagnosis, epidemiology, treatment research?
By volume in 2022–2025, Xinjiang Medical University publishes the most Brucella: diagnosis, epidemiology, treatment research, followed by Razi Vaccine and Serum Research Institute and Addis Ababa University.
By volume, 2022–2025
- 1 Xinjiang Medical University China 7 works
- 2 Razi Vaccine and Serum Research Institute Iran 7 works
- 3 Addis Ababa University Ethiopia 6 works
- 4 Shihezi University China 6 works
- 5 University of Veterinary and Animal Sciences Pakistan 6 works
- 6 Hamedan University of Medical Sciences Iran 6 works
- 7 Hopital Universitaire Hedi Chaker Tunisia 6 works
- 8 Sokoine University of Agriculture Tanzania 5 works
- 9 Universidade Federal de Minas Gerais Brazil 5 works
- 10 Mashhad University of Medical Sciences Iran 5 works
Who are the leading researchers in Brucella: diagnosis, epidemiology, treatment?
The most-cited researchers publishing on Brucella: diagnosis, epidemiology, treatment include Ziad A. Memish and Soheil Ebrahimpour.
- 1 Ziad A. Memish 5.3k citations
- 2 Soheil Ebrahimpour 2.6k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Brucella: diagnosis, epidemiology, treatment research done?
The largest centres of Brucella: diagnosis, epidemiology, treatment research in 2022–2025 are Beijing (China), Tehran (Iran), Ürümqi (China) and Addis Ababa (Ethiopia). Among places with at least 20 works in it, it is an unusually large share of all research in Ürümqi.
Largest cities, 2022–2025
- 1 Beijing China 35 works
- 2 Tehran Iran 30 works
- 3 Ürümqi China 20 works
- 4 Addis Ababa Ethiopia 14 works
- 5 Istanbul Türkiye 13 works
- 6 Moscow Russia 13 works
- 7 Hohhot China 13 works
- 8 Buenos Aires Argentina 11 works
- 9 São Paulo Brazil 10 works
- 10 Taiyuan China 10 works
Where it is the local speciality
- ÜrümqiCN · 20.1 works14×
Location quotient: how much more of its research is in Brucella: diagnosis, epidemiology, treatment than the world average.
Is Brucella: diagnosis, epidemiology, treatment research growing?
Output in 2018–2022 was 12% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Brucella: diagnosis, epidemiology, treatment.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.